United Therapeutics recently announced the first successful clinical xenotransplantation of its UKidney™ in patients with end-stage renal disease, as part of the multicenter EXPAND study at NYU ...
Anika Therapeutics, Inc. (NASDAQ: ANIK) Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on ...
On the corporate side, during the quarter, we completed our merger or reverse merger, if you like, with BerGenBio, thereby also uplisting from Euronext grows to Oslo Børs main markets. And we also ...
Palatin Technologies, Inc. ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor ...
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in nearly 1 billion devices, is announcing that it has shipped the AI ...
Trulieve Cannabis Corp. ( OTCQX:TCNNF) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Good morning, everyone, and welcome to the Trulieve Cannabis Corporation Third Quarter 2025 Financial Results ...
On October 30, 2025, the Company's Board of Directors authorized a new $750 million share repurchase program, which begins on January 1, 2026, and expires on December 31, 2028. This program is ...
Genco Shipping & Trading Limited Announces Q3 2025 Financial Results. Declares Dividend of $0.15 per share for Q3 2025 Represents Genco's 25 th Consecutive Quarterly Dividend< ...
Zacks Investment Research on MSN
Should You Buy Moderna Stock Ahead of Q3 Earnings Report?
Moderna MRNA is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate ...
Total Payment Volume increased 26.4% to $13.9 billion in the Third quarter of 2025, compared to $11 billion in the Third quarter of 2024. Excluding Sertifi, Total Payment Volume increased 24.0% to $13 ...
Brown & Brown, Inc. (NYSE: BRO) experienced a 3.2% increase in after-hours trading, reflecting a positive shift amid broader market uncertainty as investors navigate fluctuating economic signals.
Third Quarter 2025 Financial Results Compared With Third Quarter 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback